Opportunity Information: Apply for PAR 10 182

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Assay Development for High Throughput Molecular Screening (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310 Trans NIH Research Support.
  • This funding opportunity was created on Apr 30, 2010 and posted on Apr 30, 2010.
  • Applicants must submit their applications by Oct 29, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $6,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $100,000.00 in funding.
  • The number of recipients for this funding is limited to 30 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) County governments Public and State controlled institutions of higher education Independent school districts Private institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 10 182

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity "Assay Development for High Throughput Molecular Screening (R21)" (Funding Opportunity Number PAR-10-182) is a discretionary grant program designed to speed up the discovery of new research tools, specifically molecular probes that help scientists understand biological function. The core idea is to fund researchers to build, refine, or adapt biological assays so they can run reliably in automated high throughput screening (HTS) environments. In practice, this means turning a biologically meaningful assay (for example, one that reports on an enzyme, receptor, signaling pathway, or cellular phenotype) into an "HTS-ready" format that can be executed at scale with robotics, standardized reagents, and robust data readouts. Once an assay reaches that level of readiness, it can be handed off for large-scale screening to find small molecules that modulate the target or pathway, generating starting points for chemical probes and follow-on research.

A key feature of the program is its connection to the Molecular Libraries Production Centers Network (MLPCN), which was set up to run large screening campaigns against large libraries of diverse small-molecule structures. The FOA is part of the broader NIH Molecular Libraries and Imaging Roadmap Initiative, meaning the intent is not just to support one-off assay development for a single lab, but to strengthen a national pipeline where assays developed by investigators can be screened centrally, producing widely useful chemical tools that the scientific community can use to interrogate biology. In other words, the award supports the critical early step of transforming a promising biological concept into a screening-capable assay that can generate tractable hits when exposed to a large chemical collection.

The mechanism of support is a modified NIH Exploratory/Developmental Research Grant (R21). R21 awards are commonly used for early-stage, high-impact, or proof-of-concept work where the goal is to demonstrate feasibility and generate strong preliminary results, rather than to fund a long, mature research program. Here, that exploratory-developmental emphasis fits the goal: applicants are expected to focus on the engineering and validation needed to make an assay robust, reproducible, and compatible with automated HTS workflows, including considerations like signal-to-noise performance, assay stability, miniaturization, throughput, and the ability to generate consistent results suitable for screening.

For funding levels, NIH anticipated approximately $6,000,000 total available in 2011 under this announcement, spread across two due dates, with an estimated 30 total awards that year. Because assay types and development needs can vary widely, NIH noted that award size and project duration could differ from one project to another, and that final totals would depend on the number of applications, their quality, the proposed timelines, and the requested budgets. The listed award ceiling in the opportunity summary is $100,000, though applicants would still need to align budgets with the FOA-specific guidance and typical R21 constraints as described in the full announcement.

Eligibility is broad and includes many types of organizations across the public, private, nonprofit, and academic sectors. Eligible applicants include state, county, city, township, and special district governments; public and private institutions of higher education; independent school districts; public housing authorities and Indian housing authorities; nonprofits both with and without 501(c)(3) status (excluding higher education institutions in that category); for-profit organizations other than small businesses; and small businesses. The announcement also explicitly includes a wide range of additional eligible applicants such as federally eligible agencies, faith-based and community-based organizations, historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, tribal organizations (including those other than federally recognized tribal governments), regional organizations, US territories or possessions, and non-US entities (foreign organizations). The opportunity states there is no cost-sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of the award.

Administratively, the opportunity was posted and created on April 30, 2010, with an original and current closing date of October 29, 2010, and an archive date of November 29, 2010. It is categorized under Health, with CFDA number 93.310 (Trans-NIH Research Support). The sponsoring agency is the National Institutes of Health, and the full announcement was made available through the NIH grants guide, with support contacts routed through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.

Overall, this FOA is best understood as a targeted investment in the often time-consuming but essential work of assay development and assay translation into an HTS-compatible format. The payoff NIH is aiming for is a steady stream of high-quality, automation-ready assays that can be screened at scale through the MLPCN, enabling the identification of bioactive small molecules and ultimately delivering new molecular probes that can accelerate basic and translational biomedical research.

Frequently Asked Questions (FAQs): Assay Development for High Throughput Molecular Screening (R21) (PAR-10-182)

What is this NIH funding opportunity?

This opportunity is the NIH funding announcement titled "Assay Development for High Throughput Molecular Screening (R21)" with Funding Opportunity Number (FON) PAR-10-182. It is a discretionary grant program focused on speeding the discovery of new research tools, especially molecular probes that help scientists study biological function.

What is the main purpose of PAR-10-182?

The main purpose is to fund researchers to build, refine, or adapt biologically meaningful assays so they become reliable in automated high throughput screening (HTS) environments. The goal is to turn an assay into an "HTS-ready" format that can run at scale using robotics, standardized reagents, and robust readouts.

What kinds of assays are supported under this program?

The FOA describes assays that report on biological targets or systems such as enzymes, receptors, signaling pathways, or cellular phenotypes. The emphasis is on translating these assays into a screening-capable format suitable for automated HTS workflows.

What does "HTS-ready" mean in this context?

What happens after an assay becomes HTS-ready?

Once an assay reaches HTS readiness, it can be handed off for large-scale screening to identify small molecules that modulate the target or pathway. These screening results can provide starting points for chemical probes and follow-on research tools for the broader scientific community.

How is this FOA connected to the Molecular Libraries Production Centers Network (MLPCN)?

A key feature of the program is its connection to the MLPCN, which was established to conduct large screening campaigns using large libraries of diverse small-molecule structures. The intent is to feed high-quality assays into a national pipeline where centralized screening can generate widely useful chemical tools.

How does this relate to the NIH Molecular Libraries and Imaging Roadmap Initiative?

The FOA is described as part of the broader NIH Molecular Libraries and Imaging Roadmap Initiative. Rather than supporting isolated assay development efforts for a single laboratory, the program aims to strengthen a shared pipeline where assays can be centrally screened and the resulting molecular probes can be broadly useful.

What grant mechanism is used for this opportunity?

The support mechanism is a modified NIH Exploratory/Developmental Research Grant (R21). R21 awards are typically used for early-stage, high-impact, or proof-of-concept work focused on demonstrating feasibility and generating preliminary results.

Why is an R21 mechanism a fit for assay development?

The FOA frames assay development and translation to HTS as feasibility-driven work. Applicants are expected to focus on the engineering and validation needed to make the assay robust, reproducible, and compatible with automated screening workflows, which aligns with the exploratory-developmental intent of the R21 mechanism.

What kinds of development and validation considerations does NIH highlight?

The FOA highlights considerations tied to reliable automated HTS performance, including signal-to-noise performance, assay stability, miniaturization, throughput, and the ability to generate consistent results suitable for screening.

How much funding was anticipated under this announcement?

NIH anticipated approximately $6,000,000 total available in 2011 under this announcement, spread across two due dates, with an estimated 30 total awards that year. The FOA notes that final amounts depend on the number of applications, their quality, proposed timelines, and requested budgets.

How many awards did NIH estimate for 2011?

The announcement estimates about 30 total awards in 2011 under this FOA.

Is there an award ceiling mentioned in the opportunity summary?

Yes. The listed award ceiling in the opportunity summary is $100,000. The FOA also notes that award size and project duration can vary by project and should follow FOA-specific guidance and typical R21 constraints described in the full announcement.

Can project budgets and durations vary across awards?

Yes. NIH explicitly notes that because assay types and development needs differ widely, award size and project duration may vary from one project to another, and overall totals depend on application volume, quality, timelines, and requested budgets.

Who is eligible to apply?

Eligibility is broad across public, private, nonprofit, academic, and industry sectors. Eligible applicants include various government entities (state, county, city, township, special districts), public and private institutions of higher education, independent school districts, public and Indian housing authorities, nonprofits (with or without 501(c)(3) status, excluding higher education institutions in that category), for-profit organizations other than small businesses, and small businesses.

Are specific institution types explicitly included?

Yes. The FOA explicitly includes (among others) federally eligible agencies, faith-based and community-based organizations, historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, tribal organizations (including those other than federally recognized tribal governments), regional organizations, and US territories or possessions.

Are non-US (foreign) organizations eligible to apply?

Yes. The announcement explicitly includes non-US entities (foreign organizations) as eligible applicants.

Is cost sharing or matching required?

No. The opportunity states there is no cost-sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award.

What is the relevant CFDA number and category?

The FOA is categorized under Health, with CFDA number 93.310 (Trans-NIH Research Support).

Who is the sponsoring agency?

The sponsoring agency is the National Institutes of Health (NIH).

When was the opportunity posted, and what were the closing and archive dates?

The opportunity was posted and created on April 30, 2010. The original and current closing date is October 29, 2010. The archive date is November 29, 2010.

Where was the full announcement made available?

The full announcement was made available through the NIH grants guide.

Who is listed as the support contact for access or linking issues?

The FOA indicates that support contacts for access or linking issues are routed through the NIH Office of Extramural Research (OER) webmaster.

What is the bigger "payoff" NIH is aiming for with this program?

The FOA describes the intended payoff as a steady stream of high-quality, automation-ready assays that can be screened at scale through the MLPCN. This enables identification of bioactive small molecules and delivers new molecular probes that can accelerate basic and translational biomedical research.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Civic Participation Program

Previous opportunity: 2010 Voting Technology and Accessibility Research Military Heroes Initiative

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 10 182

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 10 182) also looked into and applied for these:

Funding Opportunity
Validation of Novel Therapeutic Targets for Huntingtons Disease (R01) Apply for PAS 10 183

Funding Number: PAS 10 183
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countries Apply for CDC RFA DD10 1010

Funding Number: CDC RFA DD10 1010
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $150,000
Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers Apply for CDC RFA DD10 1008

Funding Number: CDC RFA DD10 1008
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
Partnerships for Development of New Therapeutic Classes for Select Viral and Bacterial Pathogens (R01) Apply for RFA AI 10 010

Funding Number: RFA AI 10 010
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Innovative Strategies for Serving Children and Youth with Epilepsy (Project Access) Apply for HRSA 10 100

Funding Number: HRSA 10 100
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Service Area Competition Additional Areas (SAC AA) Apply for HRSA 10 223

Funding Number: HRSA 10 223
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
American Red Cross, San Juan Puerto Rico Apply for CDC RFA CK 10 006E

Funding Number: CDC RFA CK 10 006E
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Asthma and Indoor and Outdoor Air Quality Education Program Apply for CDC RFA EH10 1007

Funding Number: CDC RFA EH10 1007
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $125,000
Teenage Pregnancy Prevention Integrating Services, Programs, and Strategies through Community wide Initiatives Apply for CDC RFA DP10 1009

Funding Number: CDC RFA DP10 1009
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,500,000
NIAID Clinical Trial Planning Grant (R34) Apply for PAR 10 185

Funding Number: PAR 10 185
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 10 186

Funding Number: PAR 10 186
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 10 184

Funding Number: PAR 10 184
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Program Project on Alcohol Related Research (P01) Apply for PAR 10 187

Funding Number: PAR 10 187
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Tribal Tobacco Control Programs to Reduce Commercial Tobacco Use Among American Indians and Alaska Natives Apply for CDC RFA DP10 1002

Funding Number: CDC RFA DP10 1002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $340,000
Telehealth Resource Center Grant Program Apply for HRSA 10 151

Funding Number: HRSA 10 151
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
First Time Motherhood/New Parents Initiative Apply for HRSA 10 035

Funding Number: HRSA 10 035
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $500,000
Telehealth Network Grant Program Apply for HRSA 10 213

Funding Number: HRSA 10 213
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
MCH Research Network Programs Apply for HRSA 10 163

Funding Number: HRSA 10 163
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $150,000
Funded Community Health Centers and Title X Programs Apply for CDC RFA DD10 1006

Funding Number: CDC RFA DD10 1006
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $275,000
Occupational Safety and Health Research (R01) Apply for PAR 10 188

Funding Number: PAR 10 188
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 182", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.